by Alexander Fenkiw | Jan 31, 2025 | medical-software-whitepaper
The EU is now also regulating the use of artificial intelligence (AI) with the EU AI Act. This also affects manufacturers of software medical devices that integrate AI into their MDR medical devices. The AI Act is intended to ensure that AI systems are designed in a...
by Alexander Fenkiw | Jan 9, 2025 | medical-software-whitepaper, Unkategorisiert
At the beginning of the development of a software medical device, the central question is: Which risk class applies to my product? Risk classification has serious implications and significantly influences the cost and time frame of product development. In extreme...
by Alexander Fenkiw | Sep 10, 2024 | medical-software-whitepaper
How do I actually decide whether my product is a medical device? Where do I start when I want to determine its risk class? And what statements can I use to promote my product in the end? The answers to these and many other questions can be answered on the basis of...
by Alexander Fenkiw | Mar 17, 2024 | diga-whitepaper
The development of a digital health application (DiGA) costs time and money and involves many regulatory hurdles. As a manufacturer, you naturally have an interest in ensuring that this effort pays off in the end. You probably already know that even if your...
by Alexander Fenkiw | Mar 17, 2024 | diga-whitepaper, Unkategorisiert
We would like to quickly introduce the topic of interoperability in DiGA development with a small example: “Μια DiGA πρέπει να πληροί ορισμένες απαιτήσεις διαλειτουργικότητας.” Do you understand this sentence? Unless you speak Greek, probably not. You therefore need...